The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

Recruiting Observational Study
Prostate Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 55
Sex
Male
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Institute of Cancer Research, United Kingdom · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The i4i PRODICT® study has been developed to investigate the uptake and acceptability of the i4i PRODICT® test which combines both common and rare genetic changes (genetic variants) into one saliva-based DNA test to estimate a person's future risk of prostate cancer (PrCa) in people of varying ethnicities.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * People with a prostate\* (PwP). \*People with a prostate is defined as people born male. * Aged 40 to 55 years. * People of either (i) Black African/Black African-Caribbean; (ii) White European; or (iii) South Asian or East Asian ancestry. These are defined as individuals with…
Contacts

Eva McGrowder, PhD

+44 208 722 4483

Eva.McGrowder@icr.ac.uk

CONTACT

Elizabeth K Bancroft, PhD

+44 208 722 4483

elizabeth.bancroft@rmh.nhs.uk

CONTACT